BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

Daily Return during Q3 2024

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB Market Price 11.18% -2.89% 23.84% -1.61% 7.51% -12.74% 5.15% 3.36% 15.31% 04/07/2010
BIB NAV 11.23% -2.98% 23.86% -1.78% 7.49% -12.75% 5.15% 3.35% 15.30% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/8/10
  • Gross Expense Ratio
    1.15%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
Price
as of 7/02/2024
  • NAV
    $57.96
  • NAV Change
    $-1.31 down caret
  • Market Price
    $58.07
  • Market Price Change
    $-1.08 down caret
  • Trading Volume (M)
    16,548
  • 30-Day Median Bid Ask Spread
    0.00%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/8/10
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    1.15%
  • NAV Calculation Time
    4:00 p.m. ET
Price
as of 7/02/2024
  • NAV
    $57.96
  • NAV Change
    $-1.31 down caret
  • Market Price
    $58.07
  • Market Price Change
    $-1.08 down caret
  • Trading Volume (M)
    16,548
  • 30-Day Median Bid Ask Spread
    0.00%
  • View Premium / Discount

The expense ratio above has a contractual waiver ending 9/30/24.

Exposures

Index as of 3/28/2024

Holdings

as of 7/02/2024

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
47.89% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 40,253,542 -- 8,951 --
36.96% -- NASDAQ BIO INDEX SWAP BNP 31,061,470 -- 6,907 --
23.61% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 19,845,702 -- 4,413 --
7.07% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 5,940,669 -- 1,321 --
6.47% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 5,436,994 -- 1,209 --
5.81% REGN REGENERON PHARMACEUTICALS -- $4,883,785.50 4,675 2730190
5.80% GILD GILEAD SCIENCES INC -- $4,876,509.60 71,294 2369174
5.67% VRTX VERTEX PHARMACEUTICALS INC -- $4,767,648.14 10,063 2931034
5.54% AMGN AMGEN INC -- $4,655,645.37 14,981 2023607
4.74% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 3,984,431 -- 886 --
3.65% -- NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC 3,071,519 -- 683 --
3.25% MRNA MODERNA INC -- $2,730,423.61 23,323 BGSXTS3
2.69% AZN ASTRAZENECA PLC-SPONS ADR -- $2,260,734.36 29,364 2989044
2.45% BIIB BIOGEN INC -- $2,056,634.16 8,988 2455965
2.30% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,933,586.49 7,809 B00FWN1
1.23% ILMN ILLUMINA INC -- $1,037,585.34 9,834 2613990
1.15% BMRN BIOMARIN PHARMACEUTICAL INC -- $963,782.84 11,722 2437071
1.07% SRPT SAREPTA THERAPEUTICS INC -- $898,831.80 5,829 B8DPDT7
1.03% UTHR UNITED THERAPEUTICS CORP -- $868,399.95 2,739 2430412
1.02% ARGX ARGENX SE - ADR -- $861,399.22 1,978 BDVLM39
1.02% NBIX NEUROCRINE BIOSCIENCES INC -- $854,087.88 6,212 2623911
1.00% SNY SANOFI-ADR -- $844,110.60 17,390 2964557
0.97% INCY INCYTE CORP -- $818,902.50 13,875 2471950
0.92% MEDP MEDPACE HOLDINGS INC -- $773,655.46 1,913 BDCBC61
0.91% VTRS VIATRIS INC -- $766,667.58 73,506 BMWS3X9
0.86% RPRX ROYALTY PHARMA PLC- CL A -- $720,680.36 27,847 BMVP7Y0
0.76% INSM INSMED INC -- $641,968.50 9,953 2614487
0.61% PCVX VAXCYTE INC -- $510,895.02 6,717 BKPVGH6
0.58% ASND ASCENDIS PHARMA A/S - ADR -- $487,301.52 3,576 BV9G6B8
0.57% ROIV ROIVANT SCIENCES LTD -- $481,588.80 45,605 BMW4NZ9
0.57% BNTX BIONTECH SE-ADR -- $476,734.28 6,053 BK6H543
0.53% ITCI INTRA-CELLULAR THERAPIES INC -- $446,743.72 6,518 BHCB0P4
0.51% BPMC BLUEPRINT MEDICINES CORP -- $426,651.76 3,866 BWY52P3
0.49% JAZZ JAZZ PHARMACEUTICALS PLC -- $409,010.28 3,892 B4Q5ZN4
0.48% IONS IONIS PHARMACEUTICALS INC -- $406,756.54 9,011 BDJ0LS6
0.48% HALO HALOZYME THERAPEUTICS INC -- $403,320.60 7,862 2975098
0.47% EXEL EXELIXIS INC -- $398,323.45 17,983 2576941
0.46% CYTK CYTOKINETICS INC -- $388,212.36 7,079 BBBSBJ5
0.45% RVMD REVOLUTION MEDICINES INC -- $380,715.30 10,185 BL71K91
0.45% BGNE BEIGENE LTD-ADR -- $379,831.27 2,639 BYYWPW6
0.43% MDGL MADRIGAL PHARMACEUTICALS INC -- $357,517.72 1,316 BD59BS7
0.39% SMMT SUMMIT THERAPEUTICS INC -- $326,753.44 43,336 BMTVQS7
0.37% KRYS KRYSTAL BIOTECH INC -- $313,126.43 1,763 BD6JX35
0.34% BBIO BRIDGEBIO PHARMA INC -- $287,760.32 11,552 BK1KWG8
0.33% CRSP CRISPR THERAPEUTICS AG -- $278,428.83 5,242 BDHF4K6
0.32% NUVL NUVALENT INC-A -- $266,450.00 3,650 BMVBZD3
0.31% IBRX IMMUNITYBIO INC -- $263,848.92 42,694 BNSP0B8
0.31% APLS APELLIS PHARMACEUTICALS INC -- $262,070.16 7,492 BYTQ6X1
0.30% ALKS ALKERMES PLC -- $252,712.93 10,447 B3P6D26
0.28% IMVT IMMUNOVANT INC -- $239,130.84 9,017 BJRFSB7
0.28% AXSM AXSOME THERAPEUTICS INC -- $231,422.76 2,932 BYZR4X4
0.27% RNA AVIDITY BIOSCIENCES INC -- $229,075.20 5,904 BMWHPY1
0.27% LEGN LEGEND BIOTECH CORP-ADR -- $225,623.82 5,043 BMX9K07
0.26% CRNX CRINETICS PHARMACEUTICALS IN -- $221,688.72 4,868 BDD19F8
0.26% GH GUARDANT HEALTH INC -- $218,083.98 7,554 BFXC911
0.26% MRUS MERUS NV -- $217,085.01 4,089 BZBY005
0.25% RARE ULTRAGENYX PHARMACEUTICAL IN -- $210,206.72 5,132 BJ62Z18
0.25% DYN DYNE THERAPEUTICS INC -- $209,701.80 6,052 BN15WD1
0.23% ARWR ARROWHEAD PHARMACEUTICALS IN -- $193,386.96 7,668 BYQBFJ8
0.23% DNLI DENALI THERAPEUTICS INC -- $191,398.96 8,804 BD2B4V0
0.21% FOLD AMICUS THERAPEUTICS INC -- $180,117.10 18,286 B19FQ48
0.21% ACLX ARCELLX INC -- $175,884.75 3,303 BPCJ1Q2
0.20% SWTX SPRINGWORKS THERAPEUTICS INC -- $170,472.98 4,574 BGMGM89
0.20% XENE XENON PHARMACEUTICALS INC -- $170,369.60 4,660 BRJ3GY4
0.20% TWST TWIST BIOSCIENCE CORP -- $170,115.40 3,595 BGKG6G7
0.19% ADMA ADMA BIOLOGICS INC -- $163,134.00 14,310 B9NSBM2
0.19% ACAD ACADIA PHARMACEUTICALS INC -- $161,552.16 10,199 2713317
0.19% RYTM RHYTHM PHARMACEUTICALS INC -- $159,367.76 3,764 BF2YWG4
0.19% IDYA IDEAYA BIOSCIENCES INC -- $157,539.84 4,672 BK0VHF6
0.18% GERN GERON CORP -- $152,688.72 36,616 2370381
0.18% AGIO AGIOS PHARMACEUTICALS INC -- $147,385.25 3,505 BCBVTX1
0.17% PTCT PTC THERAPEUTICS INC -- $143,896.65 4,735 B17VCN9
0.16% MYGN MYRIAD GENETICS INC -- $138,284.60 5,585 2614153
0.16% VCEL VERICEL CORP -- $135,255.07 3,001 BSBMN89
0.16% IOVA IOVANCE BIOTHERAPEUTICS INC -- $133,543.48 17,276 BF0DMK7
0.16% NTLA INTELLIA THERAPEUTICS INC -- $131,925.40 5,956 BYZM6C2
0.16% FTRE FORTREA HOLDINGS INC -- $131,352.20 5,519 BRXYZ57
0.15% JANX JANUX THERAPEUTICS INC -- $125,799.30 3,201 BMFX8Y7
0.15% PTGX PROTAGONIST THERAPEUTICS INC -- $125,250.39 3,621 BDCBCD8
0.14% VERA VERA THERAPEUTICS INC -- $117,958.61 3,377 BL55460
0.14% GPCR STRUCTURE THERAPEUTICS INC -- $117,080.79 3,023 BQS9486
0.14% BEAM BEAM THERAPEUTICS INC -- $114,678.17 5,081 BK6L288
0.14% KYMR KYMERA THERAPEUTICS INC -- $114,473.36 3,788 BMPRZV5
0.13% AMPH AMPHASTAR PHARMACEUTICALS IN -- $113,454.02 3,019 BNFWZS4
0.13% NVAX NOVAVAX INC -- $112,423.96 8,668 BJDQXG4
0.13% NVCR NOVOCURE LTD -- $111,602.40 6,643 BYSS4X4
0.13% RCKT ROCKET PHARMACEUTICALS INC -- $110,906.46 5,607 BDFKQ07
0.13% SNDX SYNDAX PHARMACEUTICALS INC -- $108,382.36 5,246 BN7Q7R7
0.13% MORF MORPHIC HOLDING INC -- $107,040.16 3,422 BK8M4J4
0.13% APGE APOGEE THERAPEUTICS INC -- $105,994.54 2,774 BM9HHL5
0.13% EWTX EDGEWISE THERAPEUTICS INC -- $105,979.08 5,766 BKY5JZ8
0.13% HRMY HARMONY BIOSCIENCES HOLDINGS -- $105,180.00 3,506 BKSGZN7
0.12% ARVN ARVINAS INC -- $104,991.25 4,225 BDZ30Q0
0.12% RXRX RECURSION PHARMACEUTICALS-A -- $101,786.56 14,216 BM9FJ13
0.12% VCYT VERACYTE INC -- $100,347.20 4,720 BFTWZY0
0.12% MIRM MIRUM PHARMACEUTICALS INC -- $98,008.80 2,910 BJDX8Y8
0.12% KURA KURA ONCOLOGY INC -- $96,787.74 4,703 BYZD465
0.11% AKRO AKERO THERAPEUTICS INC -- $95,540.22 4,269 BK7Y2V9
0.11% KROS KEROS THERAPEUTICS INC -- $95,380.68 2,228 BM7V485
0.11% LGND LIGAND PHARMACEUTICALS -- $94,032.11 1,109 2501578
0.11% DVAX DYNAVAX TECHNOLOGIES CORP -- $89,537.48 8,081 BRJZSK0
0.10% SUPN SUPERNUS PHARMACEUTICALS INC -- $87,463.38 3,394 B72ZBG4
0.10% MNKD MANNKIND CORP -- $84,554.30 16,810 BF081J4
0.10% BCRX BIOCRYST PHARMACEUTICALS INC -- $83,447.00 12,740 2100362
0.10% AVDL AVADEL PHARMACEUTICALS -- $82,423.26 5,934 BDGMC59
0.10% ANIP ANI PHARMACEUTICALS INC -- $81,056.16 1,294 BCDWBX6
0.10% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $80,109.60 2,302 BLCD809
0.09% ARDX ARDELYX INC -- $76,264.32 14,444 BN89V40
0.09% VIR VIR BIOTECHNOLOGY INC -- $74,331.15 8,399 BK4PZ38
0.09% SANA SANA BIOTECHNOLOGY INC -- $73,155.90 13,674 BMFJJ97
0.09% DAWN DAY ONE BIOPHARMACEUTICALS I -- $72,616.70 5,395 BLB0YH0
0.08% XNCR XENCOR INC -- $69,515.82 3,807 BGCYWN8
0.08% NRIX NURIX THERAPEUTICS INC -- $69,302.73 3,661 BMVLGP2
0.08% PRTA PROTHENA CORP PLC -- $67,776.36 3,324 B91XRN2
0.08% VRNA VERONA PHARMA PLC - ADR -- $66,524.38 4,303 BYWPZK5
0.08% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $66,457.80 7,146 BKX9VD3
0.08% FDMT 4D MOLECULAR THERAPEUTICS IN -- $65,691.36 3,192 BKLXFX5
0.08% PCRX PACIRA BIOSCIENCES INC -- $65,332.02 2,873 B3X26D8
0.08% COLL COLLEGIUM PHARMACEUTICAL INC -- $64,720.80 2,020 BX7RSN3
0.08% GMAB GENMAB A/S -SP ADR -- $64,441.20 2,588 BBC9WC7
0.08% TARS TARSUS PHARMACEUTICALS INC -- $64,246.60 2,332 BMH5RL1
0.08% OCUL OCULAR THERAPEUTIX INC -- $63,874.16 9,562 BNZB1X8
0.08% INVA INNOVIVA INC -- $63,607.50 3,855 BDDXF67
0.08% IRON DISC MEDICINE INC -- $63,512.12 1,526 BMGJZJ8
0.07% ELVN ENLIVEN THERAPEUTICS INC -- $63,016.80 2,904 BMFD115
0.07% IRWD IRONWOOD PHARMACEUTICALS INC -- $61,030.64 9,812 B3MZ6K5
0.07% CGEM CULLINAN THERAPEUTICS INC -- $58,030.98 3,558 BM90J52
0.07% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $56,081.16 8,199 BMCWKZ2
0.07% ZLAB ZAI LAB LTD-ADR -- $55,184.49 3,177 BD9GVY0
0.06% TNGX TANGO THERAPEUTICS INC -- $53,452.48 6,595 BP2P6L0
0.06% RLAY RELAY THERAPEUTICS INC -- $53,015.18 8,194 BN2R582
0.06% SPRY ARS PHARMACEUTICALS INC -- $51,804.12 5,982 BMCR7V2
0.06% ABCL ABCELLERA BIOLOGICS INC -- $50,281.04 18,152 BL53SR3
0.06% GRFS GRIFOLS SA-ADR -- $49,102.12 7,531 B8K7T65
0.06% COGT COGENT BIOSCIENCES INC -- $48,632.48 5,902 BLR6XK8
0.06% AUPH AURINIA PHARMACEUTICALS INC -- $47,941.47 8,829 BFWLC09
0.06% CVAC CUREVAC NV -- $46,248.98 13,847 BN4RD42
0.05% ETNB 89BIO INC -- $46,162.40 6,074 BK1K484
0.05% -- KINIKSA PHARMACEUTICALS INTERNATIONAL PLC COMMON STOCK USD 0.000273 -- $45,903.60 2,488 --
0.05% HROW HARROW INC -- $45,557.25 2,185 BHNDW86
0.05% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $43,938.58 2,218 BKDQKM6
0.05% AUTL AUTOLUS THERAPEUTICS PLC -- $41,617.94 12,313 BFMLGR4
0.05% EOLS EVOLUS INC -- $41,200.90 3,865 BDRJH21
0.05% PETQ PETIQ INC -- $41,181.57 1,823 BDH65C8
0.05% ANAB ANAPTYSBIO INC -- $40,386.78 1,687 BDRW1L7
0.05% SAGE SAGE THERAPEUTICS INC -- $40,196.30 3,715 BP4GNK9
0.05% PLRX PLIANT THERAPEUTICS INC -- $39,474.40 3,724 BMDWW66
0.05% WVE WAVE LIFE SCIENCES LTD -- $39,457.98 7,559 BYZG9R0
0.05% PRME PRIME MEDICINE INC -- $39,119.52 7,409 BPBJFM7
0.05% TVTX TRAVERE THERAPEUTICS INC -- $38,023.00 4,700 BLFGJD5
0.04% SRRK SCHOLAR ROCK HOLDING CORP -- $37,570.12 4,924 BFZQ0L8
0.04% HUMA HUMACYTE INC -- $37,563.61 7,351 BMYTJP4
0.04% ERAS ERASCA INC -- $37,212.80 16,040 BNLYBF3
0.04% MLYS MINERALYS THERAPEUTICS INC -- $37,055.85 3,065 BP9N0G0
0.04% PHAT PHATHOM PHARMACEUTICALS INC -- $37,033.25 3,613 BJLKVS6
0.04% SVRA SAVARA INC -- $36,679.00 8,530 BYXGN81
0.04% ZYME ZYMEWORKS INC -- $36,666.00 4,365 BPCQZY9
0.04% ABUS ARBUTUS BIOPHARMA CORP -- $36,461.37 11,649 BZ0QMB7
0.04% CSTL CASTLE BIOSCIENCES INC -- $36,227.04 1,704 BKLCWZ3
0.04% OLMA OLEMA PHARMACEUTICALS INC -- $35,935.32 3,452 BMZ4LN0
0.04% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $35,721.24 1,663 BKC9SX3
0.04% LXRX LEXICON PHARMACEUTICALS INC -- $35,705.60 22,316 BWFZX59
0.04% SIGA SIGA TECHNOLOGIES INC -- $34,242.00 4,390 2107437
0.04% URGN UROGEN PHARMA LTD -- $33,777.34 2,231 BZ7PJQ1
0.04% ITOS ITEOS THERAPEUTICS INC -- $33,212.00 2,300 BMWXFT4
0.04% HCM HUTCHMED CHINA-ADR -- $32,976.30 1,915 BYXV9H7
0.04% RGNX REGENXBIO INC -- $32,680.00 3,040 BZ0G875
0.04% GLPG GALAPAGOS NV-SPON ADR -- $31,801.70 1,255 B292NQ7
0.04% REPL REPLIMUNE GROUP INC -- $31,730.67 3,791 BDDVW37
0.04% CNTA CENTESSA PHARMACEUTICALS-ADR -- $31,379.06 3,578 BLB0YQ9
0.04% ORIC ORIC PHARMACEUTICALS INC -- $31,298.24 4,162 BKVDFF7
0.04% THRD THIRD HARMONIC BIO INC -- $30,942.72 2,528 BNNPQY8
0.04% YMAB Y-MABS THERAPEUTICS INC -- $30,801.33 2,709 BG31GH0
0.04% ADPT ADAPTIVE BIOTECHNOLOGIES -- $30,653.52 9,096 BJ5FZ74
0.04% KALV KALVISTA PHARMACEUTICALS INC -- $29,972.04 2,604 BD06CS0
0.03% ALLO ALLOGENE THERAPEUTICS INC -- $27,840.24 12,889 BFZNYB7
0.03% TERN TERNS PHARMACEUTICALS INC -- $26,826.24 3,992 BMDJ0C9
0.03% OABI OMNIAB INC -- $26,644.20 7,260 BN13S71
0.03% VERV VERVE THERAPEUTICS INC -- $25,910.00 5,182 BNKGXX2
0.03% ALEC ALECTOR INC -- $25,818.66 5,949 BJ4LDC4
0.03% EYPT EYEPOINT PHARMACEUTICALS INC -- $25,760.16 3,216 BMGS7L1
0.03% VYGR VOYAGER THERAPEUTICS INC -- $25,487.22 3,358 BY7RB53
0.03% SLRN ACELYRIN INC -- $25,185.56 6,113 BQPF874
0.03% TBPH THERAVANCE BIOPHARMA INC -- $24,976.64 3,002 BMNDK09
0.03% TSHA TAYSHA GENE THERAPIES INC -- $24,937.20 11,545 BNC1BX1
0.03% -- GRAIL INC COMMON STOCK USD -- $24,666.95 1,639 --
0.03% MXCT MAXCYTE INC -- $24,005.16 6,453 BKMQF66
0.03% LYEL LYELL IMMUNOPHARMA INC -- $23,762.87 15,737 BN6MB18
0.03% ACIU AC IMMUNE SA -- $23,564.43 6,089 BZC0D70
0.03% FULC FULCRUM THERAPEUTICS INC -- $23,399.60 3,836 BJDX8Z9
0.03% PGEN PRECIGEN INC -- $23,217.18 15,582 BKM5C84
0.03% EDIT EDITAS MEDICINE INC -- $23,045.04 5,076 BZ8FPH3
0.03% CABA CABALETTA BIO INC -- $22,022.20 2,980 BK5MWR1
0.03% AVXL ANAVEX LIFE SCIENCES CORP -- $21,575.12 5,224 BYTYP72
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $21,520.64 16,813 B4N8MH9
0.02% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $20,958.50 1,255 BL95N25
0.02% TRML TOURMALINE BIO INC -- $19,866.65 1,583 BQ80NC6
0.02% VNDA VANDA PHARMACEUTICALS INC -- $18,929.84 3,592 B12W3P6
0.02% XERS XERIS BIOPHARMA HOLDINGS INC -- $18,851.06 9,151 BLR7H87
0.02% ALXO ALX ONCOLOGY HOLDINGS INC -- $18,389.80 3,215 BLN7XQ1
0.02% NAUT NAUTILUS BIOTECHNOLOGY INC -- $17,551.64 7,732 BNG1NK8
0.02% AMRN AMARIN CORP PLC -ADR -- $17,507.97 24,834 2301938
0.02% AVIR ATEA PHARMACEUTICALS INC -- $16,789.54 5,198 BLN9Z50
0.02% MGNX MACROGENICS INC -- $15,850.60 3,866 BFDV8K0
0.02% ZNTL ZENTALIS PHARMACEUTICALS INC -- $15,647.31 4,383 BMQ5T49
0.02% MGTX MEIRAGTX HOLDINGS PLC -- $15,637.86 3,969 BFYQFJ2
0.02% RVNC REVANCE THERAPEUTICS INC -- $15,572.70 6,435 BJFSR99
0.02% EXAI EXSCIENTIA PLC -- $15,417.30 3,023 BP48134
0.02% ATAI ATAI LIFE SCIENCES NV -- $13,432.90 10,333 BN6M8F1
0.01% QURE UNIQURE NV -- $12,013.96 2,996 BJFSR88
0.01% BLUE BLUEBIRD BIO INC -- $10,846.43 11,750 BBFL7S1
0.01% CHRS COHERUS BIOSCIENCES INC -- $9,843.98 7,082 BRK0149
0.01% BMEA BIOMEA FUSION INC -- $9,808.02 2,214 BNKF6N0
0.01% VTYX VENTYX BIOSCIENCES INC -- $9,311.14 4,351 BMG99Y1
0.01% CRBU CARIBOU BIOSCIENCES INC -- $8,920.00 5,575 BNYJR68
0.01% ME 23ANDME HOLDING CO -CLASS A -- $7,825.03 19,972 BM9CKX3
0.01% AMLX AMYLYX PHARMACEUTICALS INC -- $7,302.78 4,197 BPCK358
0.01% RAPT RAPT THERAPEUTICS INC -- $6,009.66 2,154 BK5T6R0
0.01% ACRS ACLARIS THERAPEUTICS INC -- $5,013.72 4,398 BYV2W40
-- MRNS MARINUS PHARMACEUTICALS INC -- $4,035.29 3,391 BM8MVZ3
-- OVID OVID THERAPEUTICS INC -- $3,386.72 4,379 BYPFK63
-- RPHM RENEO PHARMACEUTICALS INC -- $3,115.13 2,063 BMHR7T5
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $1,761.30 9,785 BM9HFX3
-- -- TREASURY BILL -- $14,921,235.00 15,000,000 BRYQ9Y9
-- -- NET OTHER ASSETS (LIABILITIES) -- $10,550,809.43 10,550,809 --

Index

as of 3/28/2024

  • Total Number of Companies218
  • Price/Earnings Ratio--
  • Price/Book Ratio4.157
  • Dividend Yield ( % )0.88
  • Avg. Index Market Capitalization$6.77 billion
About the Index

The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.